- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Webinar: How Biosimilar Rebates Shape Payer Policies, Provider Behavior
More biosimilars are hitting the US market, but marketplace dynamics have made it difficult to take advantage of these therapies.
A panel of leading experts on oncology practice and payment discussed how biosimilar rebates shape payer policies and provider options during a webinar from MJH Life Sciences™, the parent company of The American Journal of Managed Care® (AJMC®).
The discussion was held on Monday, July 20, 2020, and moderated by Jeff Prescott, PharmD, senior vice president of Clinical Communications for MJH Life Sciences™. The panelists were Kathy Oubre, MS, chief operating officer of the Pontchartrain Cancer Center in Louisiana; Timothy Chiu, PharmD, BCPS, pharmacist evidence analyst and strategist for Kaiser Permanente; and Ali McBride, PharmD, MS, BCOP, FASHP, FAzPA, clinical coordinator of Hematology/Oncology for The University of Arizona Cancer Center in Tucson.
Although more biosimilars are launching in the US market, numerous factors affect whether they actually become available in the clinic. The expectation has been that as more biosimilars are approved and launch, costs will decline and providers will have more freedom to choose the appropriate medications for their patients. However, providers who want to use biosimilars find their choices are often determined by regional payer-by-payer contracts that require careful pharmacy planning, staff training, and sometimes, compromise.
To learn more about biosimilars, visit AJMC®'s sister site, The Center for Biosimilars™.
Building Trust, Breaking Barriers: Health Care Leaders Tackle Primary Care Challenges
August 8th 2024On this episode of Managed Care Cast, we're talking with the chief medical officers of CVS Health and Aetna, as well as CVS Health's chief health equity officer, about primary and preventive care engagement, the impact of telehealth, and the role of trust in patient-provider relationships.
Listen
Frameworks for Advancing Health Equity: Health Equity by Design
July 23rd 2024Melissa Clarke, MD, CMQ, the chief health equity officer at Elevance Health, explains "Health Equity by Design" and how Elevance Health is committed to ensuring a personalized and intentional approach for all its members.
Listen
